Skip to main content
. Author manuscript; available in PMC: 2014 Dec 19.
Published in final edited form as: Neuroscience. 2013 Sep 19;254:10.1016/j.neuroscience.2013.09.025. doi: 10.1016/j.neuroscience.2013.09.025

Table 2.

Pharmacological effects on Tc and DSI activity (medians, inter-quartile range) during the 30 min post-injection interval (ZT11-ZT11.5).

Tc Activity
VEH (20) 37.05 (36.83/37.31)NS 11.4 (8.2/15.8)a
MOD (19) 37.07 (36.69/37.34)NS 27.7 (15.9/36.6)a
VEH (14) 37.23 (36.99/37.35)b 14.9 (9.3/18.8)b
MA (14) 36.68 (36.62/36.85)b 72.3 (38.4/82.4)b
VEH (14) 37.05 (36.74/37.30)c 6.2 (4.2/12.1)d,e
CAF 20mg (14) 37.32 (37.03/37.75) 22.5 (17.6/28.3)d
CAF 40mg (14) 37.54 (37.11/37.79)c 36.4 (24.9/40.3)e

NSNot significant, Mann-Whitney test; Differ

a

<.001, Mann-Whitney tests

b

<.001, Mann-Whitney tests

c

p<.05, SNK tests after significant Kruskal-Wallis ANOVA.

d

p<.05, SNK tests after significant Kruskal-Wallis ANOVA.

e

p<.05, SNK tests after significant Kruskal-Wallis ANOVA.